< Back to previous page
Researcher
Frederik Nevens
- Disciplines:Gastro-enterology and hepatology, Immunology, Paediatrics and neonatology, Nursing
Affiliations
- Hepatology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 9 of 9
- Validation and implementation of a prognostic biomarker of early graft failure after liver transplantation (GlycoTransplantTest)From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Liver transplantation for alcohol-related liver disease.From23 Jun 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Breaching the intestinal barrier during cirrhosis: a cell-by-cell analysis of how diseased macrophages fail to prevent pathological bacterial translocation to the liverFrom1 Jan 2021 → 31 Dec 2022Funding: Private funding of national origin - undefined
- Acute-on-chronic liver failure (ACLF): monocyte profiles as a predictor for progression or recovery signatures in patients.From1 Dec 2019 → 31 May 2020Funding: Private funding of national origin - undefined
- Deciphering the molecular pathways needed to restore monocyte dysfunction during Acute-on-chronic liver failureFrom1 Oct 2018 → 30 Sep 2022Funding: BOF - Concerted Research Project from 1994
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Exploring viral evolution with respect to disease progression and therapy-response in HCV infection.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Hepatocytic differentiation of hepatic progenitor cells in acute and chronic hepatocytic human liver diseases.From1 Nov 2010 → 15 Nov 2010Funding: BOF - Other initiatives
- Role of progenitor cells in liver carcinogenesis: basis for a new prognostically relevant classification of liver cancer.From1 Jan 2010 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
Publications
11 - 20 of 548
- NEUROFILAMENT LIGHT CHAIN AS POTENTIAL BIOMARKER FOR OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS(2023)
Authors: Frederik Nevens
Pages: S1402 - S1402 - PERSISTENT ACLF: CHARACTERISTICS OF THE PATIENTS IN THE PHASE IIb HEP 102-DHELIVER STUDY(2023)
Authors: Frederik Nevens
Pages: S1471 - S1473 - RESULTS FROM A PLANNED INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED TRIAL EVALUATING THE EFFECTS OF OBETICHOLIC ACID AND BEZAFIBRATE ON SERUM BIOMARKERS IN PRIMARY BILIARY CHOLANGITIS(2023)
Authors: Frederik Nevens
Pages: A7 - A7 - Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study(2023)
Authors: Hannah van Malenstein, Schalk Van der Merwe, Jef Verbeek, Frederik Nevens
Pages: 633 - 641 - Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study(2023)
Authors: Frederik Nevens
Pages: 397 - 415 - Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival(2023)
Authors: Frederik Nevens
Pages: 1497 - 1506 - Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode(2023)
Authors: Wim Laleman, Frederik Nevens
Pages: 1548 - 1557 - Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial(2023)
Authors: Frederik Nevens
Pages: 1507 - 1522 - Liver Immunosuppression Free Trial (LIFT): Outcomes of the First Biomarker-Guided Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients(2023)
Authors: Frederik Nevens
Pages: S409 - S409 - Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome(2023)
Authors: Karlien Raymenants, Frederik Nevens
Pages: 1330 - 1340